CH621788A5 - - Google Patents

Download PDF

Info

Publication number
CH621788A5
CH621788A5 CH1154278A CH1154278A CH621788A5 CH 621788 A5 CH621788 A5 CH 621788A5 CH 1154278 A CH1154278 A CH 1154278A CH 1154278 A CH1154278 A CH 1154278A CH 621788 A5 CH621788 A5 CH 621788A5
Authority
CH
Switzerland
Prior art keywords
hpi
formula
group
amino
radical
Prior art date
Application number
CH1154278A
Other languages
German (de)
English (en)
Inventor
Juergen Dr Seubert
Herbert Dr Thomas
Peter Dr Andrews
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5900929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH621788(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CH621788A5 publication Critical patent/CH621788A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fodder In General (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1154278A 1973-12-17 1978-11-09 CH621788A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2362539A DE2362539C2 (de) 1973-12-17 1973-12-17 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH621788A5 true CH621788A5 (fr) 1981-02-27

Family

ID=5900929

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1675474A CH612195A5 (fr) 1973-12-17 1974-12-17
CH1154278A CH621788A5 (fr) 1973-12-17 1978-11-09
CH1154378A CH620442A5 (fr) 1973-12-17 1978-11-09

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1675474A CH612195A5 (fr) 1973-12-17 1974-12-17

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1154378A CH620442A5 (fr) 1973-12-17 1978-11-09

Country Status (35)

Country Link
US (1) US4001411A (fr)
JP (1) JPS5826352B2 (fr)
AR (2) AR208527A1 (fr)
AT (1) AT346334B (fr)
BE (1) BE823400A (fr)
CA (1) CA1036606A (fr)
CH (3) CH612195A5 (fr)
CS (1) CS241002B2 (fr)
DD (1) DD115908A5 (fr)
DE (1) DE2362539C2 (fr)
DK (1) DK141845C (fr)
ES (2) ES432974A1 (fr)
FI (1) FI59594C (fr)
FR (1) FR2254343B1 (fr)
GB (1) GB1441554A (fr)
GR (1) GR60708B (fr)
GT (1) GT197850798A (fr)
HK (1) HK13379A (fr)
HU (1) HU170858B (fr)
IE (1) IE40124B1 (fr)
IL (1) IL46162A (fr)
IN (1) IN139511B (fr)
IT (1) IT7851978A0 (fr)
KE (1) KE2946A (fr)
LU (1) LU71204A1 (fr)
NL (1) NL185406C (fr)
NO (1) NO142304C (fr)
OA (1) OA04868A (fr)
PH (1) PH14220A (fr)
PL (3) PL99088B1 (fr)
RO (1) RO66907A (fr)
SE (1) SE422211B (fr)
SU (3) SU631070A3 (fr)
YU (1) YU41288B (fr)
ZA (1) ZA747253B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196291A (en) * 1973-12-17 1980-04-01 Merck Patent Gesellschaft Mit Beschraenkter Haftung 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4113867A (en) * 1973-12-17 1978-09-12 Merck Patent Gesellschaft Mit Beschrankter Haftung 2-acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4120961A (en) * 1974-08-28 1978-10-17 E. Merck Ring substituted pyrazino-isoquinoline derivatives and their preparation
US4162319A (en) * 1974-08-28 1979-07-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Ring substituted pyrazino-isoquinoline derivatives and their preparation
DE2441261A1 (de) * 1974-08-28 1976-03-18 Merck Patent Gmbh Ringsubstituierte pyrazino-isochinolin-derivat und verfahren zu ihrer herstellung
DE2841668A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Medikiertes tierfutter auf basis lebermehl
US4303659A (en) * 1979-08-22 1981-12-01 Pfizer Inc. Schistosomicidal compositions
FR2520740A1 (fr) * 1982-01-29 1983-08-05 Sanofi Sa Procede pour la preparation d'acyl-2-hexahydro-1,3,4,6,7,11b-2h-pyrazino (2,1-a) isoquinoleinones-4 et intermediaires
EP0134984B1 (fr) * 1983-07-16 1988-07-13 Beecham Group Plc Dérivés de la benzazépine et de la benzoxazépine
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NZ247278A (en) * 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US6429211B1 (en) 2000-05-23 2002-08-06 Bayer Corporation Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
RU2266906C1 (ru) * 2004-04-29 2005-12-27 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
KR100682506B1 (ko) * 2005-01-18 2007-02-15 (주)젠크로스 프라지콴텔, 또는 이의 염을 포함하는 약학 조성물
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
CA2609574A1 (fr) * 2005-06-09 2006-12-21 Schering-Plough Ltd. Controle de parasites chez des animaux a l'aide de derives de n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide et de n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide
FR2912145B1 (fr) * 2007-02-02 2009-03-06 Servier Lab Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ITPD20070274A1 (it) * 2007-08-08 2009-02-09 Sanypet S P A Crocchetta per animali e metodo per la sua produzione
EP2214481B1 (fr) 2007-10-15 2019-05-01 United Animal Health, Inc. Procédé permettant d'accroître la performance d'une progéniture
DE102008022520A1 (de) 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
WO2010107791A2 (fr) 2009-03-17 2010-09-23 Concert Pharmaceuticals, Inc. Composés de pyrazinoisoquinoline
CN102093346B (zh) * 2010-03-16 2012-09-05 浙江金伯士药业有限公司 一种吡喹酮的制备方法
WO2012122028A2 (fr) 2011-03-04 2012-09-13 Concert Pharmaceuticals Inc. Composés de pyrazino-isoquinoline
CN103910725B (zh) * 2013-01-09 2015-12-02 江南大学 一类吡喹酮类似物、其制备方法和用途

Also Published As

Publication number Publication date
ES441546A1 (es) 1977-04-16
CS842774A2 (en) 1985-06-13
YU41288B (en) 1987-02-28
SU631070A3 (ru) 1978-10-30
IL46162A (en) 1979-01-31
AR208715A1 (es) 1977-02-28
IE40124L (en) 1975-06-17
NO142304C (no) 1980-07-30
IL46162A0 (en) 1975-02-10
NL7416432A (nl) 1975-06-19
SE7415686L (fr) 1975-06-18
AT346334B (de) 1978-11-10
FR2254343B1 (fr) 1978-06-30
SU625613A3 (ru) 1978-09-25
NL185406B (nl) 1989-11-01
BE823400A (fr) 1975-06-16
CA1036606A (fr) 1978-08-15
DE2362539C2 (de) 1986-05-07
NO142304B (no) 1980-04-21
GB1441554A (en) 1976-07-07
PL94074B1 (fr) 1977-07-30
FI363274A (fr) 1975-06-18
AR208527A1 (es) 1977-02-15
FR2254343A1 (fr) 1975-07-11
DK141845C (da) 1980-12-22
DK141845B (da) 1980-06-30
GR60708B (en) 1978-07-24
DE2362539A1 (de) 1975-08-28
KE2946A (en) 1979-04-12
AU7643874A (en) 1976-06-17
ES432974A1 (es) 1977-02-16
PH14220A (en) 1981-04-02
SE422211B (sv) 1982-02-22
ATA996274A (de) 1978-03-15
JPS5093999A (fr) 1975-07-26
PL99105B1 (pl) 1978-06-30
JPS5826352B2 (ja) 1983-06-02
CH612195A5 (fr) 1979-07-13
RO66907A (fr) 1981-06-26
YU336174A (en) 1983-01-21
US4001411A (en) 1977-01-04
DD115908A5 (fr) 1975-10-20
SU668603A3 (ru) 1979-06-15
NL185406C (nl) 1990-04-02
FI59594B (fi) 1981-05-29
IN139511B (fr) 1976-06-26
IT7851978A0 (it) 1978-11-20
LU71204A1 (fr) 1975-04-17
HK13379A (en) 1979-03-23
HU170858B (hu) 1977-09-28
CH620442A5 (fr) 1980-11-28
OA04868A (fr) 1980-10-31
GT197850798A (es) 1979-08-01
CS241002B2 (en) 1986-03-13
FI59594C (fi) 1981-09-10
NO744521L (fr) 1975-07-14
ZA747253B (en) 1975-11-26
DK654274A (fr) 1975-08-25
PL99088B1 (pl) 1978-06-30
IE40124B1 (en) 1979-03-14

Similar Documents

Publication Publication Date Title
CH621788A5 (fr)
DE19642451A1 (de) Aminothiophencarbonsäureamide
DE2756113A1 (de) Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
CH675722A5 (fr)
EP0005231A2 (fr) Isoquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant
CH620680A5 (fr)
US4051243A (en) Ring substituted pyrazino-isoquinoline derivatives and their preparation
JPH1143489A (ja) ヘテロ環化合物、その製造法および剤
EP0005559B1 (fr) Dérivés d'acide phénylaminothiophène-acétique, procédé pour leur préparation et médicaments les contenant
DE2313227A1 (de) Neue isoindolinderivate, ihre herstellung und die medizinischen zusammensetzungen, die sie enthalten
CH678322A5 (fr)
DE2740836A1 (de) Anellierte indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4141978A (en) 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4162319A (en) Ring substituted pyrazino-isoquinoline derivatives and their preparation
US4196291A (en) 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
AT346344B (de) Verfahren zur herstellung von neuen 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)- isochinolin-derivaten, deren salzen, quartaeren ammoniumsalzen und deren optischen antipoden dieser verbindungen
CH641800A5 (de) Pyrido-pyrimidine, verfahren zu ihrer herstellung und die diese verbindungen enthaltenden arzneimittel.
US3993760A (en) Pyrazinoisoquinolines as anthelmintic agents
DE4218159C2 (de) 4,4,4-Trifluoracetessigsäureamide, Verfahren zu ihrer Herstellung und Arzneimittel
CH646170A5 (de) Pyrazolo(1,5-c)chinazolinderivate und diese enthaltende arzneimittel.
CS241008B2 (cs) Způsob přípravy 2-acyl-4-oxo-hexahydro-4H-pyrazino(2,1-a ]- isochinolinových derivátů
CH649548A5 (de) 4-phenyl-4,5,6,7-tetrahydro-pyrrolo(2,3-c)pyridine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese verbindungen enthalten.
US4120961A (en) Ring substituted pyrazino-isoquinoline derivatives and their preparation
KR800000089B1 (ko) 2-아실 -4-옥소-헥사하이드로-4H-피라지노 [2, 1-a] 이소퀴놀린 유도체의 제조방법
DE2033852A1 (de) Verfahren zur Herstellung neuer heterocychscher Verbindungen

Legal Events

Date Code Title Description
PL Patent ceased